A novel dihydroxanthenone, AGI-B4 with inhibition of VEGF-induced endothelial cell growth.
Kim
Hang Sub
HS
Park
Il Yeong
IY
Park
Yun Joo
YJ
Lee
Jeong Hyeong
JH
Hong
Young Soo
YS
Lee
Jung Joon
JJ
D020533:Angiogenesis Inhibitors / Q000737:chemistry* / Q000494:pharmacology*; D001230:Aspergillus / Q000737:chemistry / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D018360:Crystallography, X-Ray; D004353:Drug Evaluation, Preclinical; D016228:Endothelial Growth Factors / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000166:cytology* / Q000187:drug effects; D005285:Fermentation; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D020128:Inhibitory Concentration 50; D008222:Lymphokines / Q000494:pharmacology*; D009682:Magnetic Resonance Spectroscopy; D015394:Molecular Structure; D011758:Pyrroles / Q000494:pharmacology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D014966:Xanthenes / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology*
C466789:AGI B4; D020533:Angiogenesis Inhibitors; D016228:Endothelial Growth Factors; D007211:Indoles; D008222:Lymphokines; D011758:Pyrroles; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D014966:Xanthenes; D016222:Fibroblast Growth Factor 2; C116890:Semaxinib